# Biospring Partners invests in Serán Bioscience for commercial facility expansion

Serán Bioscience announced a growth investment led by Biospring Partners to accelerate expansion of its clinical-to-commercial services. A new greenfield commercial manufacturing facility in Bend, Oregon is on track for completion in Q3 2027, creating a 200,000+ sq. ft. campus.

- Type: Investment
- Announced: 2026-09-29
- Where: Bend, Oregon, United States
- Starts operating: Q3 2027
- Status: under construction
- Capacity: 200,000+ sq. ft.
- Products: spray drying, nano-milling, finished dose capabilities
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Serán BioScience](https://endata.com/companies/79855.md)
- [Vivo Capital](https://endata.com/companies/20844.md) (investor)
- [Bain Capital Life Sciences](https://endata.com/companies/79856.md) (investor)
- [Biospring Partners](https://endata.com/companies/94355.md) (investor)

## Sources

- [seranbio.com](https://www.seranbio.com/news/seran-bioscience-strengthens-spray-dry-capabilities-with-growth-investment-from-biospring-partners-to-accelerate-commercial-expansion-and-meet-surging-customer-demand), 2026-09-29: "The new capital commitment underscores Serán’s sustained commercial momentum and business success."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.